Skip to main content

Animations

MJFF Publications

6591 - 6600 of 8801 Results
Title
Year
  • Year
  • 2023
  • 2020
  • 2019
  • 2020
  • 2023
  • 2023
  • 2024
  • 2020
  • 2014
  • 2020
  • Summary Details
    OPEN
    Title: Novel human pluripotent stem cell-derived hypothalamus organoids demonstrate cellular diversity
    Journal Name: iScience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.isci.2023.107525
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Distinct Roles for RAB10 and RAB29 in Pathogenic LRRK2-Mediated Endolysosomal Trafficking Alterations
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells9071719
    Citation Count: 30
  • Summary Details
    OPEN
    Title: LRRK2 inhibition does not impart protection from α-synuclein pathology and neuron death in non-transgenic mice
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-019-0679-5
    Citation Count: 45
  • Summary Details
    OPEN
    Title: Generalization of deep learning models for ultra-low-count amyloid PET/MRI using transfer learning
    Journal Name: European Journal of Nuclear Medicine and Molecular Imaging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00259-020-04897-6
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Parkinson's disease relevant pathological features are manifested in male Pink1/Parkin deficient rats
    Journal Name: Brain, Behavior, & Immunity - Health
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bbih.2023.100656
    Citation Count: 7
  • Summary Details
    OPEN
    Title: A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic Inflammation
    Journal Name: Drugs
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s40265-023-01838-z
    Citation Count: 32
  • Summary Details
    OPEN
    Title: Associating white matter microstructural integrity and improvements in reactive stepping in people with Parkinson’s Disease
    Journal Name: Brain Imaging and Behavior
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s11682-024-00867-w
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.51022
    Citation Count: 76
  • Summary Details
    RESTRICTED
    Title: Prodromal features for Parkinson's disease – baseline data from the TREND study
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/ene.12382
    Citation Count: 114
  • Summary Details
    OPEN
    Title: The Sigma-2 Receptor/TMEM97, PGRMC1, and LDL Receptor Complex Are Responsible for the Cellular Uptake of Aβ42 and Its Protein Aggregates
    Journal Name: Molecular Neurobiology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s12035-020-01988-1
    Citation Count: 66
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.